HHS warns drugmakers that won't give 340B discounts to contract pharmacies
The agency sent warning letters to AstraZeneca, Eli Lilly, Novartis, Novo Nordisk, Sanofi and United Therapeutics. They could face fines of up to $5,000 per overcharge if they don't start following the rules and issue refunds.
|READ MORE >|
Post a Comment